Photo by Pixabay on Pexels.com

Canopy Growth Corp Stock (CGC) Current Outlook

A Quick Synapsis of CGC Stock’s Short-Term and Current Outlook

(By Glenford S. Robinson)

Canopy Growth Corp (NYSE: CGC) will reverse its downward trend when the price gets to about $27 per share; this is when it will reverse back toward its mean of around $28 per share.

CGC stock will remain at these price levels for a while until there is a positive news catalyst that will catapult the stock back up toward the $40 area where it will stay for a day before it begins its downward trend back toward its weekly moving average of $28 per share.

The stock is currently trading at the 31.70-33.83 price range as of this writing (Oct. 30, 2018).

At the present time, investors who bought into the Canadian legalization rumor/hype are now taking profits now that legalization has become a reality in Canada.

These investors who are now taking profits will eventually buy back the stock when it gets to the $27 price level. This is what smart money does. Smart money is the term used for investors who are successful players in the stock market trading game.

Less savvy traders will exit the market as a result of such low CGC price levels. And this is when smart money gobbles up their spoils.

It is highly unlikely that the stock will head back up the charts up toward the $53 level anytime soon unless there is an amazing news catalyst. With that said, the stock will eventually get back on its uptrend trajectory, but there will be some stagnation before this happens.

These inferences were devised by employing the Mstardom Finance proprietary trading strategy. To receive analysis on your favorite stock, please subscribe at Mstardom.com

Note: We do not provide analysis of pump and dump penny stocks. The stock must have solid fundamentals or a tangible money-making business strategy before we analyze it.

Granted that some stocks trade at very low prices because these stocks have fallen out of favor with Wall Street. Stocks such as these do not qualify as pump and dumps. Pump and dump stocks are those stocks that do not have a tangible money-making business strategy.

Disclosure: I/we/Mstardom Finance is long on CGC.

Disclaimer: ©Mstardom, Inc., Mstardom.com, Mstardom Finance does not provide investment advice.

Check Also

GDP Growth Slowed

US Economy Starts to Slow Entering 2019, but Headwinds Ease

The Federal Reserve has signaled that it will postpone further interest rate hikes until signs of rising inflation emerge and cease balance sheet normalization activities towards the end of this year. Stock price gains since the announcement of these policy shifts illustrate that if they are executed, business confidence is likely to rise.

Where can I get business financing?

Horizon Technology Finance Provides Investment Portfolio Update Increases Portfolio Size with $24 Million in Loan Originations; Grows Committed Backlog to $47 Million

"During the third quarter, we experienced solid investment activity, increasing the size of our portfolio and expanding our committed backlog for the second consecutive quarter," said Gerald A. Michaud, President of Horizon. "Our success funding seven loans, totaling more than $24 million, and growing our committed backlog to $47 million underscores the strong demand for our venture debt products to growing life science and technology companies. We believe Horizon will continue to benefit from a robust pipeline of investment opportunities and is well positioned to deliver long-term, disciplined portfolio growth, while ensuring credit quality remains strong."

ECB profit increased in 2018

Financial Statements of the ECB for 2018

The ECB’s net profit is distributed to the euro area national central banks (NCBs). The Governing Council decided to make an interim profit distribution, amounting to €1,191 million, to the euro area NCBs on 31 January 2019. At yesterday’s meeting, the Governing Council decided to distribute the remainder of the profit, amounting to €384 million, on 22 February 2019.

Litigation Photo

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

The investigation concerns whether the Immune Design board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Immune Design shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $9.00 price target on the stock and the Company has approximately $100 million in cash and no long-term debt.

Mergers and Acquisitions

Merck to Acquire Immune Design; Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer

“Scientists at Immune Design have established a unique portfolio of approaches to cancer immunization and adjuvant systems designed to enhance the ability of a vaccine to protect against infection, which could meaningfully improve vaccine development," said Dr. Roger M. Perlmutter, president, Merck Research Laboratories. “This acquisition builds upon Merck’s industry-leading programs that harness the power of the immune system to prevent and treat disease.”

SEC Files Charges in Elaborate Microcap Stock Fraud

“As alleged in our complaint, Magna Group and its co-defendants used fake debt instruments to unlawfully obtain shares in microcap companies, which they then dumped on unsuspecting retail investors,” said Sanjay Wadhwa, Senior Associate Director of the SEC’s New York Regional Office. “This action demonstrates the resolve of the SEC in pursuing fraudsters who use elaborate financing schemes to engage in securities fraud.”

Investor Alert and Bulletin From SEC Office of Investor Education and Advocacy

Know how to be a better investor. Did you know that active trading and some other very common investing behaviors actually can undermine investment performance? According to researchers, other common investing mistakes include focusing on past performance, favoring investments from your own country, region, state, or company, and holding on to losing investments too long and selling winning investments too soon.

%d bloggers like this: